Linked Life Data

17673608

Source:http://linkedlifedata.com/resource/pubmed/id/17673608

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-8-3
pubmed:abstractText
A higher incidence of central nervous system (CNS) metastases in HER-2-positive metastatic breast cancer (MBC) has recently been reported.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1083-7159
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
766-73
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17673608-Adult, pubmed-meshheading:17673608-Aged, pubmed-meshheading:17673608-Antibodies, Monoclonal, pubmed-meshheading:17673608-Antibodies, Monoclonal, Humanized, pubmed-meshheading:17673608-Antineoplastic Agents, pubmed-meshheading:17673608-Breast Neoplasms, pubmed-meshheading:17673608-Central Nervous System Neoplasms, pubmed-meshheading:17673608-Disease Progression, pubmed-meshheading:17673608-Female, pubmed-meshheading:17673608-Genes, erbB-2, pubmed-meshheading:17673608-Humans, pubmed-meshheading:17673608-Incidence, pubmed-meshheading:17673608-Middle Aged, pubmed-meshheading:17673608-Neoplasm Metastasis, pubmed-meshheading:17673608-Regression Analysis, pubmed-meshheading:17673608-Retrospective Studies, pubmed-meshheading:17673608-Risk Factors, pubmed-meshheading:17673608-Survival Analysis, pubmed-meshheading:17673608-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
pubmed:affiliation
Medical Oncology Division, Azienda Ospedaliera Perugia, Via Dottori 1, Perugia, Italy. stefania.gori@tin.it
pubmed:publicationType
Journal Article